Aiyuan Biomedicine's and Hongri Pharmaceutical's R&D laboratory projects obtain preliminary public notice of EIA

On March 16, 2022, the preliminary public notices of EIA on the molecular biology and functional medicine research & development (R&D) laboratory project of Sichuan Aiyuan Biomedical Science and Technology Co., Ltd. (Aiyuan Biomedicine) and the innov...

Amino Acids China E-News 202204

www.cnchemicals.com